J-GLOBAL ID:201801011108341262   Update date: Sep. 01, 2020

Nakama Takahito

ナカマ タカヒト | Nakama Takahito
Papers (25):
  • Yoshito Koyanagi, Shigeo Yoshida, Yoshiyuki Kobayashi, Yuki Kubo, Takahito Nakama, Keijiro Ishikawa, Shintaro Nakao, Toshio Hisatomi, Yasuhiro Ikeda, Yuji Oshima, et al. Visual Outcomes Based on Early Response to Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema. Ophthalmologica. 2018. 239. 2-3. 94-102
  • Yoshida S, Nakama T. Periostin in vitreoretinal diseases. Cell Mol Life Sci. 2017. 74. 23. 4329-4337
  • Berdasco M, Yoshida S, Nakama T. DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated Disorders. Sci Rep. 2017. 7. 1. 11762
  • Zhou Y, Yoshida S, Nakama T. Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization. Mol Med Rep. 2017. 15. 6. 3949-3956
  • Takahito Nakama, Shigeo Yoshida, Keijiro Ishikawa, Yuki Kubo, Yoshiyuki Kobayashi, Yedi Zhou, Shintaro Nakao, Toshio Hisatomi, Yasuhiro Ikeda, Kazumasa Takao, et al. Therapeutic Effect of Novel Single-Stranded RNAi Agent Targeting Periostin in Eyes with Retinal Neovascularization. MOLECULAR THERAPY-NUCLEIC ACIDS. 2017. 6. 279-289
Education (2):
  • 2012 - 2016 Kyushu University 眼科学
  • 2002 - 2008 Kyushu University 医学科
Professional career (1):
  • 博士(医学) (九州大学)
Association Membership(s) (3):
日本糖尿病眼学会 ,  日本網膜硝子体学会 ,  日本眼科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page